Telix Pharmaceuticals Limited Profit Margin

The latest profit margin for TLPPF is 2.56% as of June 2026. That compares with -1.97% in the prior-year period — up 230.0% year over year. That is below the Healthcare sector average of 9.71%. Investors often review this figure alongside Telix Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, TLPPF's profit margin moved from -1.97% to 2.56% — a 230.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Telix Pharmaceuticals Limited's valuation or profitability profile.

Against Healthcare companies, TLPPF currently prints 2.56% for profit margin, while the sector average sits near 9.71%. That is roughly 73.6% below the sector mean. Large gaps often invite a closer look at Telix Pharmaceuticals Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Telix Pharmaceuticals Limited converts resources into returns. At 2.56%, TLPPF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.97% in the prior-year period — up 230.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TLPPF's profit margin (2.56%), review year-over-year change from -1.97%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.